- Gut-on-a-Chip Research for Drug Development: Implications of Chip Design on Preclinical Oral Bioavailability or Intestinal Disease Studies
- 2'-Fucosyllactose inhibits proliferation of Clostridioides difficile ATCC 43599 in the CDi-screen, an in vitro model simulating Clostridioides difficile infection
- A Novel, Orally Bioavailable, Small-Molecule Inhibitor of PCSK9 With Significant Cholesterol-Lowering Properties In Vivo
- Applicability of generic PBK modelling in chemical hazard assessment: A case study with IndusChemFate
- The potential of multi-organ-on-chip models for assessment of drug disposition as alternative to animal testing
- Towards human ex vivo organ perfusion models to elucidate drug pharmacokinetics in health and disease
- Setting the stage for next-generation risk assessment with non-animal approaches the EU-ToxRisk project experience
- Characterization of Human Induced Pluripotent Stem Cell-Derived Hepatocytes with Mature Features and Potential for Modeling Metabolic Diseases
- COST Action 'ImpARAS': What have we learnt to improve food allergy risk assessment. A summary of a 4 year networking consortium
- Appetite ratings of foods are predictable with an in vitro advanced gastrointestinal model in combination with an in silico artificial neural network
- Applying the adverse outcome pathway (AOP) for food sensitization to support in vitro testing strategies
- The relevance of a digestibility evaluation in the allergenicity risk assessment of novel proteins. Opinion of a joint initiative of COST action ImpARAS and COST action INFOGEST
- Interactions between acetylcholinesterase, toxic organophosphorus compounds and a short series of structurally related non-oxime reactivators: Analysis of reactivation and inhibition kinetics in vitro
- Air-liquid interface In Vitro models for respiratory toxicology research: Consensus workshop and recommendations